Table 2 Clinical Characteristics of study participants (N = 211)
Characteristic | Frequency | Percentage |
|---|---|---|
Substance use in the past 3 months (n = 204) | ||
 No | 190 | 93.4 |
 Yes | 14 | 6.6 |
Type of substance used (n = 14) | ||
 Tobacco | 6 | 42.9 |
 Alcoholic beverage | 8 | 57.1 |
Frequency of substance use (n = 14) | ||
 Once/twice | 10 | 71.4 |
 Monthly | 4 | 28.6 |
BDI II Scorea | Â | Â |
Median = 1 (IQR: 0,4) |  |  |
Age at diagnosis of HIV (n = 202) | ||
  < 10 years | 164 | 81.2 |
  ≥ 10 years | 38 | 18.8 |
 Median = 11 years (IQR: 9,12) |  |  |
WHO HIV clinical stage | ||
 Stage I | 201 | 95.3 |
 Stage II & III | 10 | 4.7 |
ART regimen | ||
 1st line | 208 | 98.6 |
 2nd line | 3 | 1.4 |
Duration on ART | ||
Between 1 & 6Â months | 6 | 2.8 |
 > 6 months | 205 | 97.2 |
CD4 count | Â | Â |
 < 200 cells/mm3 | 14 | 6.6 |
 ≥ 200 cells/mm3 | 197 | 93.4 |
Mean = 559.5 (SD = 226.0) |  |  |
Viral load | ||
 Undetected | 197 | 93.4 |
 Detected | 14 | 6.6 |
ART adherence | ||
 Adherent | 132 | 62.6 |
 Non-adherent | 79 | 37.4 |
ART non-adherence factors (n = 79) | ||
 Patient factors | 76 | 96.2 |
 Other factors | 3 | 3.8 |